📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Cerebrospinal fluid IL-1ß is elevated in tuberculous meningitis patients but not associated with mortality. (2021)

First Author: Koeken VACM

Attributed to: High Dose Oral Rifampicin to Improve Survival from Adult TB Meningitis - (HARVEST) Trial funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.tube.2020.102019

PubMed Identifier: 33202351

Publication URI: http://europepmc.org/abstract/MED/33202351

Type: Journal Article/Review

Volume: 126

Parent Publication: Tuberculosis (Edinburgh, Scotland)

ISSN: 1472-9792